Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.60 |
| ▸ | ACLY | P53396 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | CTSA | P10619 | 1/20 | 0.43 |
| ▸ | BRD4 | O60885 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | PARP1 | P09874 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | AGER | Q15109 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29861782 | 1.00 | L3MBTL1 (0.60) | L3MBTL1ACLYALOX15MAP2K1HTT | |
| SCHEMBL31621400 | 0.84 | L3MBTL1 (0.46) | L3MBTL1ACLYALOX15ALDH1A1KDM4E | |
| SCHEMBL1711562 | 0.81 | CTNNB1 (0.42) | L3MBTL1ALOX15HTTALDH1A1KDM4E | |
| SCHEMBL18232551 | 0.81 | L3MBTL1 (0.40) | L3MBTL1ALOX15HTTALDH1A1KDM4E | |
| SCHEMBL69177 | 0.81 | L3MBTL1 (0.64) | L3MBTL1ALOX15MAP2K1HTTALDH1A1 | |
| SCHEMBL30322596 | 0.81 | L3MBTL1 (0.41) | L3MBTL1ACLYALOX15ALDH1A1KDM4E | |
| SCHEMBL31453471 | 0.81 | BRD4 (0.60) | L3MBTL1HTTALDH1A1KDM4ENPSR1 | |
| SCHEMBL16505732 | 0.81 | BRD4 (0.60) | L3MBTL1HTTALDH1A1KDM4ENPSR1 | |
| SCHEMBL28423158 | 0.81 | MAPT (0.46) | L3MBTL1ALDH1A1KDM4ENPSR1CTSA | |
| SCHEMBL128711 | 0.79 | L3MBTL1 (0.62) | L3MBTL1ALOX15MAP2K1HTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026105052-A1 | BIARYL ACID COMPOUNDS | PFIZER INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| US-20260138982-A1 | Biaryl Acid Compounds | PFIZER INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-20260015341-A1 | PI3K INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | HINOVA PHARMACEUTICALS INC (CN) | 2026-01-15 | — | — | US | disclosed |
| EP-4055021-B1 | HETEROCYCLIC RIP1 INHIBITORY COMPOUNDS | RIGEL PHARMACEUTICALS INC (US) | 2025-10-08 | — | — | EP | disclosed |
| EP-4025568-B1 | RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME | RIGEL PHARMACEUTICALS INC (US) | 2025-05-14 | — | — | EP | disclosed |
| EP-4553075-A1 | PI3K INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | Hinova Pharmaceuticals Inc. (CN) | 2025-05-14 | — | — | EP | disclosed |
| EP-4025574-B1 | RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME | RIGEL PHARMACEUTICALS INC (US) | 2025-05-07 | — | — | EP | disclosed |
| US-20250092057-A1 | HETEROCYCLIC RIP1 INHIBITORY COMPOUNDS | RIGEL PHARMACEUTICALS, INC. | 2025-03-20 | — | — | US | disclosed |
| CN-116134035-B | 3- (1H-imidazol-2-yl) -2,3,8 a-tetrahydroindol-5 (1H) -one derivatives useful as factor XIA inhibitors | 詹森药业有限公司 | 2025-03-11 | — | — | CN | disclosed |
| US-20240368119-A1 | RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME | RIGEL PHARMACEUTICALS, INC. | 2024-11-07 | — | — | US | disclosed |
| US-20090306395-A1 | METALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2009-12-10 | — | — | US | disclosed |
| US-7566781-B2 | Imidazopyridine compound | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2009-07-28 | — | — | US | disclosed |
| US-20080275239-A1 | Metallic Compound and Organic Electroluminescence Device Comprising the Same | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2008-11-06 | — | — | US | disclosed |
| US-20080275239-A1 | Metallic Compound and Organic Electroluminescence Device Comprising the Same | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2008-11-06 | — | — | US | disclosed |
| US-20080207905-A1 | Metallic Compound and Organic Electroluminescence Device Comprising the Same | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2008-08-28 | — | — | US | disclosed |
| US-20080207905-A1 | Metallic Compound and Organic Electroluminescence Device Comprising the Same | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2008-08-28 | — | — | US | disclosed |
| US-20080200678-A1 | Metallic Compound and Organic Electroluminescence Device Comprising the Same | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2008-08-21 | — | — | US | disclosed |
| US-20080200678-A1 | Metallic Compound and Organic Electroluminescence Device Comprising the Same | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2008-08-21 | — | — | US | disclosed |
| US-20070249659-A1 | melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide | BANYU PHARMACEUTICAL., LTD. (JP) | 2007-10-25 | — | — | US | disclosed |
| EP-1748048-A1 | IMIDAZOPYRIDINE COMPOUND | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2007-01-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249659-A1 | melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide | MC1R, MCHR2, MCHR1 | L3MBTL1 1869/4885ACLY 4332/4885ALOX15 1331/4885 |
| US-20260138982-A1 | Biaryl Acid Compounds | PIK3R1, PIK3R3, PIK3R5 | L3MBTL1 3536/4885ACLY 2622/4885ALOX15 2491/4885 |
| US-20240368119-A1 | RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME | RIPK1, RIPK2, RIPK3 | L3MBTL1 1049/4885ACLY 3294/4885ALOX15 2648/4885 |
| US-20080200678-A1 | Metallic Compound and Organic Electroluminescence Device Comprising the Same | RPS10, SCO2, NFE2L2 | L3MBTL1 379/4885ACLY 1275/4885ALOX15 1120/4885 |
| US-20260015341-A1 | PI3K INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | PIK3CA, PIK3R4, PIK3R1 | L3MBTL1 1917/4885ACLY 3117/4885ALOX15 2728/4885 |
| US-20080275239-A1 | Metallic Compound and Organic Electroluminescence Device Comprising the Same | SCO2, NFE2L2, SOD1 | L3MBTL1 1973/4885ACLY 2754/4885ALOX15 1212/4885 |
| US-20090306395-A1 | METALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME | SCO2, RPS4Y1, RER1 | L3MBTL1 1665/4885ACLY 2521/4885ALOX15 789/4885 |
| US-20250092057-A1 | HETEROCYCLIC RIP1 INHIBITORY COMPOUNDS | RIPK1, RIPK2, RIPK3 | L3MBTL1 2180/4885ACLY 3185/4885ALOX15 2761/4885 |
| US-20080207905-A1 | Metallic Compound and Organic Electroluminescence Device Comprising the Same | NOX5, PRMT5, SIRT5 | L3MBTL1 1581/4885ACLY 3061/4885ALOX15 869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.